- Country: Italy
- Summary: Preliminary Market Consultation - Totally Covered Stent for the Treatment of Acute And/Or Refractory Hemorrhages from Left Esophageal Varices-Ella Stent Danis (Ref. Di Viesto)
- ITT Ref No: 106854817
- Deadline: 10 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 16802/2024/EF/FDV
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Preliminary Market Consultation - Totally Covered Stent for the Treatment of Acute and/or Refractory Hemorrhages from Esophageal Varices Left-Ella Stent Danis (Ref. Di Viesto)
Product Categories: various medical devices and products. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPreliminary Market Consultation - Totally Covered Stent for the Treatment of Acute And/Or Refractory Hemorrhages from Left Esophageal Varices-Ella Stent Danis (Ref. Di Viesto) - Italy Tender
The A.O.U. CITY OF HEALTH AND SCIENCE OF TURIN, a Government sector organization in Italy, has announced a new tender for Preliminary Market Consultation - Totally Covered Stent for the Treatment of Acute And/Or Refractory Hemorrhages from Left Esophageal Varices-Ella Stent Danis (Ref. Di Viesto). This tender is published on ItalyTenders under ITT Ref No: 106854817 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
